Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung | 16 | 2021 | 507 | 3.900 |
Why?
|
| Pulmonary Emphysema | 3 | 2024 | 22 | 2.550 |
Why?
|
| Emphysema | 3 | 2024 | 15 | 2.540 |
Why?
|
| Pancreatic Elastase | 6 | 2024 | 15 | 2.310 |
Why?
|
| alpha 1-Antitrypsin | 3 | 2019 | 19 | 1.470 |
Why?
|
| Trachea | 4 | 2021 | 51 | 1.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2018 | 205 | 1.070 |
Why?
|
| Fibroblasts | 6 | 2021 | 386 | 1.000 |
Why?
|
| Pulmonary Alveoli | 2 | 2014 | 20 | 0.980 |
Why?
|
| Stress, Mechanical | 2 | 2021 | 96 | 0.920 |
Why?
|
| Acute Lung Injury | 1 | 2023 | 19 | 0.910 |
Why?
|
| Fetus | 3 | 2021 | 228 | 0.910 |
Why?
|
| Mice | 17 | 2024 | 6428 | 0.860 |
Why?
|
| Lung Injury | 1 | 2022 | 25 | 0.850 |
Why?
|
| Organoids | 1 | 2021 | 41 | 0.810 |
Why?
|
| High-Frequency Jet Ventilation | 1 | 2021 | 6 | 0.790 |
Why?
|
| Animals | 20 | 2024 | 14402 | 0.730 |
Why?
|
| Scoliosis | 1 | 2020 | 58 | 0.720 |
Why?
|
| Spinal Fusion | 1 | 2020 | 71 | 0.710 |
Why?
|
| Mice, Inbred C57BL | 9 | 2021 | 2002 | 0.710 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 462 | 0.710 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2021 | 35 | 0.700 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2019 | 8 | 0.700 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2019 | 29 | 0.690 |
Why?
|
| Respiratory Insufficiency | 1 | 2021 | 127 | 0.690 |
Why?
|
| Elastin | 4 | 2024 | 22 | 0.660 |
Why?
|
| Body Fluids | 1 | 2018 | 26 | 0.660 |
Why?
|
| Sheep | 1 | 2018 | 88 | 0.660 |
Why?
|
| Airway Obstruction | 1 | 2018 | 51 | 0.640 |
Why?
|
| Chymases | 2 | 2015 | 3 | 0.630 |
Why?
|
| Sex Characteristics | 1 | 2019 | 213 | 0.610 |
Why?
|
| Morphogenesis | 1 | 2015 | 20 | 0.510 |
Why?
|
| Peritoneal Cavity | 2 | 2016 | 6 | 0.510 |
Why?
|
| Child | 9 | 2023 | 7372 | 0.510 |
Why?
|
| Pneumonectomy | 1 | 2014 | 27 | 0.510 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2014 | 6 | 0.490 |
Why?
|
| Elasticity | 1 | 2014 | 30 | 0.490 |
Why?
|
| Sepsis | 3 | 2023 | 250 | 0.490 |
Why?
|
| Disease Models, Animal | 5 | 2023 | 1651 | 0.480 |
Why?
|
| Cell Differentiation | 3 | 2023 | 720 | 0.470 |
Why?
|
| Models, Animal | 3 | 2021 | 254 | 0.450 |
Why?
|
| Swine | 2 | 2024 | 429 | 0.430 |
Why?
|
| PPAR gamma | 1 | 2012 | 81 | 0.400 |
Why?
|
| Humans | 18 | 2024 | 54304 | 0.390 |
Why?
|
| Drowning | 1 | 2010 | 6 | 0.380 |
Why?
|
| Central Nervous System Diseases | 1 | 2010 | 30 | 0.370 |
Why?
|
| Fetoscopy | 2 | 2021 | 2 | 0.360 |
Why?
|
| Central Nervous System | 1 | 2010 | 86 | 0.360 |
Why?
|
| Echinocandins | 1 | 2009 | 64 | 0.350 |
Why?
|
| Recovery of Function | 1 | 2010 | 222 | 0.340 |
Why?
|
| Candidiasis | 1 | 2009 | 122 | 0.330 |
Why?
|
| Mice, Transgenic | 3 | 2014 | 658 | 0.320 |
Why?
|
| Embryo, Mammalian | 3 | 2021 | 69 | 0.260 |
Why?
|
| Mice, Knockout | 3 | 2018 | 928 | 0.250 |
Why?
|
| Appendiceal Neoplasms | 1 | 2004 | 10 | 0.250 |
Why?
|
| Carcinoid Tumor | 1 | 2004 | 21 | 0.250 |
Why?
|
| Colectomy | 1 | 2004 | 33 | 0.240 |
Why?
|
| Appendectomy | 1 | 2004 | 41 | 0.240 |
Why?
|
| Keratin-8 | 1 | 2023 | 3 | 0.240 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2023 | 9 | 0.240 |
Why?
|
| Enzyme Activation | 2 | 2015 | 328 | 0.240 |
Why?
|
| Cells, Cultured | 4 | 2016 | 1737 | 0.230 |
Why?
|
| Acceleration | 1 | 2023 | 16 | 0.230 |
Why?
|
| Multiple Organ Failure | 1 | 2023 | 56 | 0.230 |
Why?
|
| Mesoderm | 2 | 2021 | 33 | 0.230 |
Why?
|
| Thorax | 1 | 2023 | 15 | 0.230 |
Why?
|
| Critical Illness | 2 | 2023 | 343 | 0.230 |
Why?
|
| Respiratory System | 1 | 2023 | 28 | 0.230 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2023 | 93 | 0.220 |
Why?
|
| Animals, Newborn | 2 | 2014 | 396 | 0.220 |
Why?
|
| Nose | 1 | 2022 | 42 | 0.210 |
Why?
|
| Female | 9 | 2021 | 28457 | 0.200 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2021 | 187 | 0.200 |
Why?
|
| Repressor Proteins | 1 | 2022 | 165 | 0.200 |
Why?
|
| NF-kappa B | 1 | 2023 | 336 | 0.200 |
Why?
|
| Xenon Isotopes | 1 | 2020 | 1 | 0.190 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 2389 | 0.190 |
Why?
|
| Adolescent | 2 | 2023 | 6896 | 0.180 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2020 | 128 | 0.180 |
Why?
|
| Treatment Outcome | 4 | 2020 | 5609 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 125 | 0.170 |
Why?
|
| Tubulin | 1 | 2018 | 28 | 0.170 |
Why?
|
| Transcriptome | 1 | 2020 | 346 | 0.160 |
Why?
|
| Aging | 1 | 2024 | 782 | 0.160 |
Why?
|
| Male | 7 | 2020 | 27335 | 0.160 |
Why?
|
| Models, Biological | 1 | 2021 | 825 | 0.160 |
Why?
|
| Oxygen | 1 | 2021 | 361 | 0.160 |
Why?
|
| Phenotype | 1 | 2020 | 820 | 0.150 |
Why?
|
| Prenatal Care | 1 | 2018 | 118 | 0.150 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1229 | 0.150 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2016 | 6 | 0.150 |
Why?
|
| Neutrophil Infiltration | 1 | 2016 | 29 | 0.140 |
Why?
|
| Capillary Permeability | 1 | 2016 | 40 | 0.140 |
Why?
|
| Zinc | 1 | 2016 | 59 | 0.140 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 1064 | 0.140 |
Why?
|
| Neutrophils | 1 | 2016 | 154 | 0.130 |
Why?
|
| Proteomics | 1 | 2018 | 343 | 0.130 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 175 | 0.130 |
Why?
|
| Elastic Modulus | 1 | 2015 | 11 | 0.130 |
Why?
|
| Reperfusion Injury | 1 | 2016 | 117 | 0.130 |
Why?
|
| Tensile Strength | 1 | 2015 | 33 | 0.130 |
Why?
|
| Tissue Distribution | 1 | 2015 | 178 | 0.130 |
Why?
|
| Intestines | 1 | 2016 | 204 | 0.120 |
Why?
|
| Pregnancy | 2 | 2021 | 2637 | 0.120 |
Why?
|
| Regeneration | 1 | 2014 | 72 | 0.120 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 766 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1141 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 1616 | 0.110 |
Why?
|
| Liver | 1 | 2019 | 1226 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 151 | 0.110 |
Why?
|
| Esterification | 1 | 2012 | 6 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 151 | 0.110 |
Why?
|
| Pulmonary Surfactants | 1 | 2010 | 18 | 0.090 |
Why?
|
| Young Adult | 1 | 2020 | 4313 | 0.090 |
Why?
|
| Shock, Septic | 1 | 2011 | 80 | 0.090 |
Why?
|
| Hydroxamic Acids | 1 | 2010 | 47 | 0.090 |
Why?
|
| Kidney | 1 | 2015 | 821 | 0.090 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2010 | 56 | 0.090 |
Why?
|
| Child, Preschool | 3 | 2020 | 4161 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 141 | 0.090 |
Why?
|
| Amphotericin B | 1 | 2009 | 122 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 183 | 0.090 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2010 | 138 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2023 | 2604 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 426 | 0.080 |
Why?
|
| Histones | 1 | 2010 | 335 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2012 | 1751 | 0.060 |
Why?
|
| Angiopoietin-2 | 1 | 2023 | 16 | 0.060 |
Why?
|
| Prognosis | 2 | 2023 | 2126 | 0.060 |
Why?
|
| Developing Countries | 1 | 2023 | 51 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2004 | 600 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2023 | 255 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2009 | 2923 | 0.050 |
Why?
|
| Pennsylvania | 1 | 2020 | 35 | 0.050 |
Why?
|
| Helium | 1 | 2020 | 2 | 0.050 |
Why?
|
| Diffusion | 1 | 2020 | 20 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2020 | 125 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 1294 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2023 | 1361 | 0.040 |
Why?
|
| Infant | 2 | 2020 | 3832 | 0.040 |
Why?
|
| Logistic Models | 1 | 2020 | 991 | 0.040 |
Why?
|
| Pediatrics | 1 | 2020 | 324 | 0.040 |
Why?
|
| Peroxidase | 1 | 2016 | 19 | 0.040 |
Why?
|
| Phagocytosis | 1 | 2016 | 51 | 0.040 |
Why?
|
| Claudin-3 | 1 | 2016 | 5 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2018 | 398 | 0.040 |
Why?
|
| Tight Junction Proteins | 1 | 2016 | 10 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2016 | 42 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 3430 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 128 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 271 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2013 | 3 | 0.030 |
Why?
|
| Receptor, TIE-2 | 1 | 2013 | 18 | 0.030 |
Why?
|
| Cytokines | 1 | 2016 | 677 | 0.030 |
Why?
|
| Epithelium | 1 | 2013 | 68 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2013 | 17 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2013 | 52 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 55 | 0.030 |
Why?
|
| Wnt Proteins | 1 | 2013 | 110 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 94 | 0.030 |
Why?
|
| Cell Death | 1 | 2013 | 223 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 233 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2011 | 28 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2004 | 6462 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2013 | 293 | 0.030 |
Why?
|
| Inflammation | 1 | 2016 | 679 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 288 | 0.020 |
Why?
|
| Pulmonary Fibrosis | 1 | 2010 | 20 | 0.020 |
Why?
|
| Methylation | 1 | 2010 | 130 | 0.020 |
Why?
|
| CpG Islands | 1 | 2010 | 104 | 0.020 |
Why?
|
| Aged | 1 | 2004 | 10054 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2010 | 129 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 1090 | 0.020 |
Why?
|
| Gene Expression | 1 | 2011 | 664 | 0.020 |
Why?
|
| Middle Aged | 1 | 2004 | 13076 | 0.020 |
Why?
|
| Adult | 1 | 2004 | 14189 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 1083 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 520 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 399 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1476 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2010 | 575 | 0.020 |
Why?
|
| Rats | 1 | 2010 | 3417 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 3207 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 3934 | 0.010 |
Why?
|